Sex‐Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation

BACKGROUND: Sex‐specific effectiveness of rivaroxaban (RIVA), dabigatran (DABI), and warfarin in reducing myocardial infarction (MI), heart failure (HF), and all‐cause mortality among patients with atrial fibrillation are not known. We assessed sex‐specific associations of RIVA, DABI, or warfarin us...

Descripción completa

Detalles Bibliográficos
Autores principales: Palamaner Subash Shantha, Ghanshyam, Mentias, Amgad, Inampudi, Chakradhari, Kumar, Anita A., Chaikriangkrai, Kongkiat, Bhise, Viraj, Deshmukh, Abhishek, Patel, Nileshkumar, Pancholy, Samir, Horwitz, Phillip A., Mickelsen, Steven, Bhave, Prashant D., Giudici, Michael, Oral, Hakan, Vaughan Sarrazin, Mary S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586467/
https://www.ncbi.nlm.nih.gov/pubmed/28862952
http://dx.doi.org/10.1161/JAHA.117.006381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586467/
https://www.ncbi.nlm.nih.gov/pubmed/28862952
http://dx.doi.org/10.1161/JAHA.117.006381

Ejemplares similares